An immune-based biomarker signature is associated with mortality in COVID-19 patients.
JCI Insight. 2021 Jan 11;6(1):e144455. doi: 10.1172/jci.insight.144455.
JCI Insight. 2021.
PMID: 33232303
Free PMC article.